US 11952365
Anti-viral compounds
granted A61KA61K31/404A61K31/4178
Quick answer
US patent 11952365 (Anti-viral compounds) held by Aligos Therapeutics, Inc. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/404, A61K31/4178, A61K31/428, A61K31/437